Literature DB >> 1889262

Mycobacterium gordonae: a possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection.

T W Barber1, D E Craven, H W Farber.   

Abstract

STUDY
OBJECTIVE: To determine if Mycobacterium gordonae is an opportunistic respiratory tract pathogen in patients infected with human immunodeficiency virus, type 1 (HIV-1).
DESIGN: Retrospective review of medical records of all patients with positive cultures for M gordonae from 1987 to 1989. PATIENTS: Fifteen patients had positive sputum cultures for M gordonae: five patients had AIDS or had HIV-1 infections with less than or equal to 180 CD4 cells/cu mm, and ten patients had no clinical evidence of HIV-1 infection.
RESULTS: Three of the five HIV-1 infected patients had clinical, roentgenographic, and microbiologic evidence of pulmonary infection due to M gordonae that responded to antimycobacterial therapy. One of the two remaining HIV-1 infected patients had disseminated M tuberculosis and possible coinfection with M gordonae, and the other was lost to follow-up. None of the ten patients without evidence of HIV-1 infection was considered to have M gordonae respiratory tract infection.
CONCLUSIONS: Sputum isolates of M gordonae should be considered potential opportunistic respiratory tract pathogens in patients with advanced HIV-1 infection and with otherwise unexplained pulmonary infection.

Entities:  

Mesh:

Year:  1991        PMID: 1889262     DOI: 10.1378/chest.100.3.716

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Total synthesis of an antigenic heptasaccharide motif found in the cell-wall lipooligosaccharide of Mycobacterium gordonae strain 989.

Authors:  Chinmoy Mukherjee; Anup Kumar Misra
Journal:  Glycoconj J       Date:  2008-02-19       Impact factor: 2.916

3.  Concise synthesis of a heptasaccharide antigen found in the cell-wall lipopolysaccharide of Mycobacterium gordonae strain 990.

Authors:  Rajib Panchadhayee; Anup Kumar Misra
Journal:  Glycoconj J       Date:  2008-06-21       Impact factor: 2.916

4.  Repeated acute kidney injury associated with Mycobacterium gordonae infection.

Authors:  Tomohiro Murata; Eiji Ishikawa; Takayasu Ito; Hiroshi Matsuo; Akiko Nakamura; Satoshi Mitarai; Shinsuke Nomura; Masaaki Ito
Journal:  CEN Case Rep       Date:  2014-10-24

5.  Heterogeneity of RNA polymerase gene (rpoB) sequences of Mycobacterium gordonae clinical isolates identified with a DNA probe kit and by conventional methods.

Authors:  Saotomo Itoh; Yuko Kazumi; Chiyoji Abe; Mitsuyoshi Takahashi
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Characterization of non-tuberculous mycobacterium from humans and water in an Agropastoral area in Zambia.

Authors:  Ngula Monde; Musso Munyeme; Adrian Muwonge; John Bwalya Muma; Sydney Malama
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.